Is Elanco Animal Health Inc (ELAN) a risky stock?
As of July 29, 2026, Clavix grades Elanco Animal Health Inc (ELAN) B- for risk, a composite score of 70 out of 100 on an A+ to F scale, which puts ELAN in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 29, 2026. Clavix regrades every trading day.
The five risk dimensions behind ELAN's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ELAN scores on each, as of July 29, 2026.
What's moving ELAN's risk right now
Company-specific signals Clavix flags behind ELAN's current grade, drawn from recent news and filings as of July 29, 2026.
Elanco challenged PetIQ's advertising through BBB's National Advertising Division. The NAD found some PetIQ claims had a reasonable basis but recommended others be modified or discontinued, a mixed outcome for Elanco.
Morgan Stanley kept a neutral 'equal weight' rating with a modest upside revision, while another rating cited 15.59% upside potential. Allspring Global Investments also opened a new position in ELAN during Q1.
A head-to-head comparison found Elanco's Credelio Quattro kills ticks faster than competitor Simparica Trio. The efficacy edge could help Credelio Quattro grab share in the parasiticides market.
Recent ELAN news
The latest headlines Clavix ingested for Elanco Animal Health Inc, newest first. These feed the news-sentiment dimension of ELAN's grade.
-
UBS analyst identified Elanco Animal Health (ELAN) as the 'best-positioned name' among animal health stocks heading into the Q2 earnings print, with the article mentioning IDEXX Laboratories. The article body was truncated, limiting additional details.
-
Morgan Stanley raised its price target on Elanco Animal Health (NYSE:ELAN) from $23.00 to $26.00 while maintaining an 'equal weight' rating in a Wednesday report.
What a B- grade means
On the Clavix A+ to F scale, ELAN's composite of 70 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ELAN or any security. Grades are risk indicators, not predictions of return. Data may be delayed.